November 20 2025
TNF inhibitors help control autoimmune diseases but raise cancer risk concerns. Data shows no overall increase in cancer, but skin cancer risk is slightly higher. Etanercept may be safer than adalimumab. Screening and timing matter more than avoidance.
SEE MORE
